Explore the 8 possible supplements interactions for 3-Iodobenzylguanidine and the research papers that mention these ...

"Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG." J Nucl Med 36, no. 4 (April ... "Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG." J Nucl Med, vol. 36, no. 4, ... Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.. Publication , Journal Article ... Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG. J Nucl Med. 1995 Apr;36(4):644 ...

Experimental studies have shown that cytokine production by the heart may be regulated by sympathetic nervous system stimulation of cardiac beta-adrenergic receptors. Proinflammatory cytokine levels are increased in heart failure, whereas cardiac fixation of 123-I-metaiodobenzylguanidine (MIBG) has …

Giammarile F, Chiti A, Lassmann M, Brans B, Flux G (May 2008). "EANM procedure guidelines for 131I-meta-iodobenzylguanidine ( ... ISBN 978-3-319-68872-5. S2CID 52922868. Taïeb D, Hicks RJ, Hindié E, Guillet BA, Avram A, Ghedini P, et al. (September 2019). " ... doi:10.1007/s00259-008-0715-3. PMID 18274745. S2CID 6884201. Van Vickle SS, Thompson RC (June 2015). "123I-MIBG Imaging: ...

Assessment of cardiac adrenergic supply in mitral valve prolapse using m-[123I]iodobenzylguanidine scintigraphy. Int J Cardiol ... Reports vary, but 3-5% of pediatric patients likely have clinically significant mitral valve prolapse. However, a report from ... Atrioventricular valve morphology and dynamics in congenital heart disease as imaged with real-time 3-dimensional matrix-array ... Accuracy of real-time 3-dimensional echocardiography in the assessment of mitral prolapse. Is transesophageal echocardiography ...

I-123 meta-iodobenzylguanidine, I-123-MIBG). If uncontaminated I 123, discontinue breastfeeding for 12, 24 or 48 hours ... I-123 as sodium iodide (123 I-NaI). If uncontaminated with I 125: doses up to 20 MBq (0.5 mCi) waiting time= 3 to 6 hours. If ... 3 weeks (Sachs 2013, ICRP 2008). For more safety, you can request to measure the amount of radioactivity of the milk in the ... 3 weeks (Sachs 2013, ICRP 2008). I-123 as ioflupane: Stop breastfeeding from 1 day (Society of Nuclear Medicine, Djang 2012) to ...

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic ...

A radioisotope (MIBG, iodine-131-meta-iodobenzylguanidine, or iodine-123-meta-iodobenzylguanidine) is injected into a vein. ... Adrenal medullary imaging; Meta-iodobenzylguanidine scintiscan; Pheochromocytoma - MIBG; Neuroblastoma - MIBG; Carcinoid MIBG ... You may need to return for repeated scans for 1 to 3 days. Each scan takes 1 to 2 hours. ...

123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis ... Although pheochromocytomas have classically been associated with 3 syndromes-von Hippel-Lindau (VHL) syndrome, multiple ...

Radiation therapy to a field that includes the thyroid gland and 131 I-meta-iodobenzylguanidine ( 131 I-MIBG) treatment are the ... Abstract Thyroid cancer is a disease that affects 8,000 new individuals a year, a number that has increased approximately 3- ...

... meta-iodobenzylguanidine, [(1)F]fluorodopamine, and [(3)H]norepinephrine in mouse pheochromocytoma cells and tumors after ... 3 Feng F, Zhu Y, Wang X, Wu Y, Zhou W, Jin X, Zhang R, Sun F, Kasoma Z, Shen Z. Predictive factors for malignant ... 3 Department of Endocrine Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA ... 3 Department of Endocrine Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA ...

A radioisotope (MIBG, iodine-131-meta-iodobenzylguanidine, or iodine-123-meta-iodobenzylguanidine) is injected into a vein. ... Adrenal medullary imaging; Meta-iodobenzylguanidine scintiscan; Pheochromocytoma - MIBG; Neuroblastoma - MIBG; Carcinoid MIBG ... You may need to return for repeated scans for 1 to 3 days. Each scan takes 1 to 2 hours. ...

... usually with meta-iodobenzylguanidine (MIBG).. ... 3 The presenting symptoms are sustained or paroxysmal ...

... evaluating induction therapy followed by meta-iodobenzylguanidine labeled with iodine-131 and chemotherapy in treating patients ... Presented at: 2022 ASCO Annual Meeting; June 3-7, 2022; Chicago, IL. Abstract 10005. ... with high-risk neuroblastoma treated in 3 upfront COG trials from 2007 to 2016: ANBL0532 (NCT00567567) evaluating 2 high-dose ...

m Iodobenzylguanidine m-Iodobenzylguanidine meta Iodobenzylguanidine meta-Iodobenzylguanidine Iobenguane (131I) - Narrower ... m Iodobenzylguanidine. m-Iodobenzylguanidine. meta Iodobenzylguanidine. meta-Iodobenzylguanidine. Tree number(s):. D02.078. ... 3-Iodobenzylguanidine - Preferred Concept UI. M0029373. Scope note. A guanidine analog with specific affinity for tissues of ... 125I Labeled 3-Iodobenzylguanidine 3 Iodobenzylguanidine, 125I Labeled (3-Iodo-(131I)benzyl)guanidine - Narrower Concept UI. ...

3, p. 302-308 7 p.. Research output: Contribution to journal › Article › peer-review ...

A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I ... 3, p. 399-405 7 p.. Research output: Contribution to journal › Article › peer-review ...

Dive into the research topics where Marie Boyd is active. These topic labels come from the works of this person. Together they form a unique fingerprint ...

3, p. 299-308 10 p.. Research output: Contribution to journal › Article › peer-review ...

Neuroblastoma, MIBG, 131I-MIBG, Resistant, Relapsed, Treatment, University of California, San Francisco, Pediatric, Oncology, 3 ... Iodobenzylguanidine, Metaiodobenzylguanidine (MIBG). Eligibility. You can join if… Open to people ages 1 year and up ... Patients with active infections that meet grade 3-4 toxicity criteria.. *Patients with pheochromocytoma or paraganglioma who ...

A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51 ...

Cardiac uptake of [(123)I] meta-iodobenzylguanidine was normal in both patients. Analysis of genotype-phenotype correlations ... High-field 3 T MRI revealed a small high-intensity lesion on fast spin-echo short inversion time inversion-recovery images of ... 3. A novel ZC4H2 gene mutation, K209N, in Japanese siblings with arthrogryposis multiplex congenita and intellectual disability ... This is the first report detecting a hippocampal lesion by 3 T MRI, which could not be found by conventional 1.5 T MRI. ...

Increased uptake of [123I]meta-iodobenzylguanidine, [18F]fluorodopamine, and [3H]norepinephrine in mouse pheochromocytoma cells ...

Iodine-131 meta-iodo-benzylguanidine (MIBG) scintigraphy is a valuable tool in the detection of neuroendocrine tumors. This has ... Bronchial carcinoids are not associated with smoking, whereas small cell lung cancer (neuroendocrine type 3) has a definite ... Tyr3]octreotate therapy reported significant improvement in global health status, quality of life, and symptoms of insomnia, ... and tumor uptake increases 3-fold, improving tumor visualization. When11 C-labeled 5-HTP PET scanning is used during the ...

... iodobenzyl)guanidine. [11C]b-CIT. methyl 3-(4-iodocyclohexyl)-8-[11C]methyl-8-azabicyclo[3.2.1]octane-2-carboxylate. Articles ... 2E,2E)-3,3-[(2,2-dimethylpropane-1,3-diyl)diimino]dibutan-2-one dioximato-oxo[99mTc]technetium(V) [99mTc]MIBI. Hexa(1- ... G Ital Dermatol Venereol 2018;153 (3 Suppl 2), 20-5.. Books and monographs. For occasional publications, the names of authors, ... No more than 1000 words (3 typed, double-spaced pages) and up to 15 references will be accepted.. Original articles. These ...

A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and ...

Iobenguane I 131 is described as I 131 meta-iodobenzylguanidine. The molecular weight is 279.1 Daltons and the structural ... Table 3: Recommended Dose or Dose Reduction for Second Therapeutic Dose of AZEDRA for Myelosuppression Patient Population. If ... 3. Dosage Forms and Strengths. Injection: 555 MBq/mL (15 mCi/mL) as a clear, colorless to pale yellow solution in a single-dose ... icon (Figure 3) or the icon (Figure 4). Note: the running icon will disappear when the monitor is stopped. ...

Research data supporting Flexible Synthesis Scheme and Application of AuNP Surface-Conjugatable Meta-Iodobenzylguanidine ... Research data supporting, Flexible Synthesis Scheme and Application of AuNP Surface-Conjugatable Meta-Iodobenzylguanidine ... CT Data of UMMP VP 68409, Plesiadapis gingerichi, left dentary with P/4-M/1, M/2 trigonid, P/3 roots (holotype). ... Reconstructed CT slices for Left dentary with P/4-M/1, M/2 trigonid, P/3 roots of Plesiadapis gingerichi (University of ...

Iodine-123 meta-iodo-benzylguanidine myocardial imaging in asymptomatic patients, with chronic kidney disease.[AUT.] B[EATA] E ... 3 nr 4 s. 141-153, bibliogr. poz. 50, sum.. *Miażdżyca aorty u osób z chorobą niedokrwienną serca oceniana przy zastosowaniu ... Munich, 30 August - 3 September 2008. Abstr [b. pag.] P1278.. *Influence of head-up tilt test provocation on autonomic nervous ... Munich, 30 August - 3 September 2008. Abstr [b. pag.] P3634.. *Type 1 diabetes mellitus and silent myocardial ischemia.[AUT.] T ...